ANDAs: Impurities in Drug Substances: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 15, 2009
November 27, 2024
f8f33332-d6b5-44e6-a308-aa86ea6fa74f
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
ANDAs: Stability Testing of Drug Substances and Products
Guidance DocumentJune 20, 2013Center for Drug Evaluation and Research
ANDAs: Impurities in Drug Products: Guidance for Industry
Guidance DocumentNovember 29, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox